AHIP Warns Proposed ACA Exchange Rule Could Threaten Market’s Growing Stability

AHIP, the top lobbying organization for commercial insurers, is warning the feds that provisions in its proposed rule governing the Affordable Care Act’s exchanges for 2023 could “undermine” the growing stability there. For instance, the group says in comments (PDF) submitted late Thursday that potential changes to requirements for essential health benefits would limit the ability for ...

Read More

House Passes Insulin Bill Over Insurers’ Opposition

Despite concerns about the bill’s policy and strategy from both sides of the aisle, nearly all House Democrats as well as a dozen Republicans voted for it Thursday.

Read More

California Setting Up Statewide Medical Data-Exchange Grid

California is developing a long-sought statewide health information exchange for providers and payers to deliver better care for patients. The health information exchange, or HIE, has received little public attention. But it would cover 40 million people in California’s 58 counties, and would in part quickly inform emergency room doctors and nurses of a patient’s ...

Read More

Hospital Prices For Health Plans Vary Widely Across The U.S., Study Finds

Regional healthcare markets across the country have experienced significant divergence in commercial-to-Medicare price ratios between 2012 and 2019, causing insurers to pay wildly different rates to hospital systems. In areas like Chico, California and Tacoma, Washington, private payers saw hospital price ratios increase by over 100 percentage points. On the other end of the spectrum, ...

Read More

Medicare Advantage Insurers Get A Pay Bump

Private insurers who administer Medicare Advantage plans can expect a 5% average increase in federal payments next year — half a percentage point above what the Biden administration proposed in February. Why it matters: The pay bump in the controversial program marks a big win for insurers like UnitedHealth Group and Humana and doused speculation the ...

Read More

Senators Reach $10 Billion Covid Funding Deal For Therapeutics, Vaccines And Testing

Senate Republicans and Democrats reached a deal Monday on $10 billion in additional Covid funding to buy therapeutics and vaccines and maintain the nation’s testing capacity if another Covid wave hits the U.S. The legislation earmarks at least $5 billion to purchase and develop Covid treatments such as antiviral pills. Another $750 million is set ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square